Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing

Megan A. Allyse, David H. Robinson, Matthew J. Ferber, Richard R. Sharp

Research output: Contribution to journalReview articlepeer-review

61 Scopus citations


Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.

Original languageEnglish (US)
Pages (from-to)113-120
Number of pages8
JournalMayo Clinic proceedings
Issue number1
StatePublished - Jan 2018

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing'. Together they form a unique fingerprint.

Cite this